A method for continuously preparing rosuvastatin intermediates using a microchannel modular reaction device
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2022-05-20
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for preparing an intermediate of statin blood lipid-lowering drug rosuvastatin, in particular to a method for preparing an important intermediate of rosuvastatin 4-(4-fluorophenyl)- Method for methyl 6-isopropyl-2-(methylamino)pyrimidine-5-carboxylate. Background technique
[0002] Rosuvastatin, chemical name (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(methyl-methylsulfonyl-amino)- Pyrimidin-5-yl]-3,5-dihydroxy-6-heptenoic acid, which is a selective hydroxymethylglutaryl coenzyme (HMG-CoA) reductase inhibitor, competes for HMG-CoA reductase, Thereby reducing cholesterol biosynthesis and causing increased clearance of cholesterol from the blood. The main site of action of rosuvastatin is the liver-the target organ for lowering cholesterol. It increases the number of receptors on the surface of liver LDL cells, promotes the absorption and catabolism of LDL, and inhibits the hepatic synthesis of VLDL, thereby reduci...